Petersen M R, Vine A K
W. K. Kellogg Eye Center, University of Michigan, Ann Arbor 48105.
Ophthalmology. 1990 Apr;97(4):496-500; discussion 501-2. doi: 10.1016/s0161-6420(90)32556-3.
The progression of diabetic retinopathy after combined pancreatic and kidney transplantation was studied in eight patients for 12 to 49 months. Four patients who had rapid pancreatic graft failure constituted a control group for comparison with four patients who retained functioning grafts. Using Fisher's exact probability test, the authors found no posttransplantation difference between the two groups in visual acuity lost, severity of diabetic macular edema, extent of capillary closure, progression of preretinal gliosis, development of disc or preretinal neovascularization, or worsening of the severity of the retinopathy. Achievement of normoglycemia by pancreatic transplantation is not effective in halting the progression of diabetic retinopathy in patients who already have severe diabetic microangiopathy joined the current follow-up.
对8例患者进行了12至49个月的胰腺和肾脏联合移植术后糖尿病视网膜病变进展情况的研究。4例胰腺移植迅速失败的患者组成对照组,与4例移植肾功能良好的患者进行比较。作者使用Fisher精确概率检验发现,两组在移植后视力丧失、糖尿病性黄斑水肿严重程度、毛细血管闭塞范围、视网膜前胶质增生进展、视盘或视网膜前新生血管形成以及视网膜病变严重程度恶化方面均无差异。胰腺移植实现血糖正常化对于已经患有严重糖尿病微血管病变的患者停止糖尿病视网膜病变进展无效,本研究纳入了这些患者进行随访。